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UNUSUAL UPPER GASTROINTESTINAL BLEEDING
DUE TO LATE METASTASIS FROM RENAL CELL
CARCINOMA: A CASE REPORT
Wen-Tsan Chang, Chee-Yin Chai,1 and King-Teh Lee
Departments of Surgery and 1Pathology, Kaohsiung Medical University Hospital,
Kaohsiung, Taiwan.
A case of recurrent massive upper gastrointestinal bleeding originating from metastatic renal cell carcinoma
is reported. A 63-year-old woman underwent right nephrectomy 9 years previously and experienced no
recurrence during follow-up. A gradually enlarging ulcerative tumor over the bulb of the duodenum and
four subsequent episodes of massive bleeding from this tumor occurred between June 2001 and March
2002. The patient underwent surgery in April 2002 for intractable bleeding from the tumor. Renal cell
carcinoma metastasis to the duodenum was confirmed from the surgical specimen. Upper gastrointestinal
bleeding due to malignancy is very rare and the duodenum is the least frequently involved site. Furthermore,
a solitary late renal cell carcinoma metastasis 9 years after a nephrectomy is extremely uncommon. This
case suggests that life-long follow-up of renal cell carcinoma patients is necessary, owing to unpredictable
behavior and the possibility of long disease-free intervals. In nephrectomized patients suffering from
gastrointestinal bleeding, complete evaluation, especially endoscopic examination, is indicated. The
possibility of late recurrent renal cell carcinoma metastasis to the gastrointestinal tract should be kept
in mind, although it is rare. If the patient is fit for surgery, metastatectomy is the first choice of treatment.
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Common metastatic sites for renal cell carcinoma (RCC) are
the lungs, bone, liver, adrenal glands, and brain. Uncommon
sites include the thyroid gland, gallbladder, pancreas, and
orbit [1]. The gastrointestinal tract is an unusual location for
solitary late recurrence of RCC [2,3]. Among solitary late
metastases, duodenal metastases from RCC are uncommon
and have been reported only in sporadic cases [4–7]. In
addition, massive gastrointestinal tract bleeding originating
from metastases is also encountered rarely, accounting for
only 0.06% of all cases of metastatic tumors in a large pan-
endoscopic series [8].
Late solitary recurrence of RCC presenting with recurrent
upper gastrointestinal tract bleeding is therefore very rare
[9]. Although patients surviving disease-free for 8 years
following nephrectomy can be considered cured [9], there
have been reports of late recurrence developing 10 to 30
years after nephrectomy [2]. In this paper, we report a 63-
year-old woman who underwent right nephrectomy for
RCC and presented with late duodenal metastasis mani-
festing as recurrent massive upper gastrointestinal bleeding
9 years later.
CASE PRESENTATION
A 54-year-old woman underwent right radical nephrectomy
for RCC at our hospital in 1992. The classification was clear-
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cell cancer, T2N0M0, stage II. No involved lymph nodes
or distant metastases were detected at that time and
adjuvant therapy was not administered after the operation.
The patient remained in good health during 9 years of
follow-up.
In June 2001, at the age of 63, she suffered from an epi-
sode of massive melena and marked anemia. A duodenal
ulcer over the bulbar area was initially detected by endo-
scopy, and blood transfusion and anti-peptic ulcer therapy
was administered. Unfortunately, the patient suffered from
several episodes of massive upper gastrointestinal bleeding
and severe anemia. A gradually growing protruding ul-
cerative mass over the posterior wall of the duodenal bulb
was found at repeat endoscopy (Figure 1). Endoscopic
biopsy specimens taken between August 2001 and March
2002 revealed an inflammatory polyp and necrotizing in-
flammation with some dysplastic cells only. No intestinal
obstruction, perforation, or intussusception had been
induced by the tumor. Because of recurrent massive bleed-
ing and a gradually enlarging duodenal tumor, the patient
was referred to the surgical department of our hospital in
March 2002. On admission, no palpable abdominal mass or
regional lymphadenopathy was detected. The patient’s
hemoglobin was 5.9 g/dL and her hematocrit was 18.6%,
as revealed by a complete blood count. Serum levels of the
tumor markers CA19-9 and carcinoembryonic antigen
(CEA) were 18.9 U/mL and 0.82 ng/mL, respectively.
Abdominal magnetic resonance imaging (MRI) showed
a lobulated tumor (2.6 = 2.8 cm) in the second portion of the
duodenum. There were no enlarged lymph nodes and no
intra-abdominal metastases were found in the liver, pan-
creas, opposite kidney, or adrenal gland. To treat the intrac-
table recurrent duodenal bleeding caused by this tumor,
and due to the suspicion of malignancy, the patient under-
went laparotomy in April 2002. A grayish white tumor with
an ulcerative surface and measuring 1.4 = 1.5 = 3 cm was
found 1 cm distal to the pyloroduodenal junction.
Malignancy was confirmed by pathologic examination
of frozen sections of ulcer biopsy. Radical subtotal gastrec-
tomy was subsequently performed because Vater’s am-
pulla and the pancreas were not affected. The cancer cells
had infiltrated and entirely replaced the muscle layer. From
comparison with specimens obtained from her right
nephrectomy 9 years earlier, it was concluded that this
tumor was RCC metastasis to the duodenum (Figure 2).
Six regional lymph nodes showed chronic lymphadenitis
but there was no apparent metastasis or invasion of other
intra-abdominal organs.
The postoperative course was uneventful, except for
mild episodes of paralytic ileus, and the patient was dis-
charged 27 days after surgery. There was no evidence of
recurrence at 10 months.
DISCUSSION
Duodenal metastasis from RCC is very rare [4]. Only 7.1%
of gastrointestinal metastases are from RCC, and only 4% of
RCC metastasizes to the small intestine [10]. In postmortem
and endoscopic series, gastrointestinal tract metastases oc-
cur in 0.06% to 4% of patients with malignant disease, and
gastrointestinal bleeding secondary to metastases is also
infrequent [8,10–12]. The most common gastrointestinal
tract metastases originate from breast cancer (8.2–33%),
melanoma (10–26%), lung cancer (14%), and squamous cell
carcinoma of the esophagus [8]. The small intestine is in-
volved in just 2% of all gastrointestinal tract metastases [10].
Furthermore, the incidence of apparently solitary metastases
is only 1% to 3% among all metastases, with the duodenum
being the least frequent site [6]. According to recent literature,
there have been only 17 cases of duodenal metastases due to
RCC reported as of 2001 [4]. However, in most of these
cases, the primary and metastatic tumors were found at the
same time. Therefore, late metastasis of RCC presenting as
a solitary duodenal tumor with recurrent upper gastro-
intestinal bleeding [2], as in this case, is very unusual.
The natural history and behavior of RCC remains
unpredictable and poorly understood, in spite of intensive
study. RCC may remain stable for long periods without
growing and metastasizing, and metastases may develop
many years after removal of the primary tumors [13–15].
This may be due to the long tumor doubling time, which
Figure 1. The ulcer became a protruding mass with partial obstruction
of the duodenal bulb, as revealed by repeated endoscopy in March 2002.
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accounts for the delayed appearance of metastases and also
permits longer survival of the host [16]. Although patients
who have disease-free survival for 8 years following ne-
phrectomy can be considered cured [9], as was the present
case, late recurrence is seen in 5% to 11% of patients who
survive 10 years from the date of nephrectomy [14,15].
The possible mechanisms of duodenal involvement of
RCC may be via direct invasion by the tumor or through
lymphatic, transcelomic, or hematogenous spread [6,17].
Microscopic examination of the resected specimen reveal-
ed that the cancer cells had invaded the serosa and muscu-
lar layer of the duodenum, although its mucosa was not
remarkable. Six regional lymph nodes revealed chronic
lymphadenitis only. In the presented case, metastasis was
via hematogenous spread or direct invasion.
The major complications of duodenal metastases from
RCC are obstruction, intussusception, and bleeding [4–6,
12,17]. Metastatectomy can improve survival in patients
with a solitary metastatic lesion and should be performed if
patients are fit for surgery [2,3,6,13]. Metastatectomy can
result in a 5-year survival rate of 31% to 35%, which compares
favorably with the known 5-year survival of 13% to 17% in
nephrectomized patients with metastatic disease [6,18].
Maldazys and deKernion concluded that a longer disease-
free interval was associated with longer average survival,
particularly when the interval exceeded 24 months [16].
There is no role for chemotherapy or radiotherapy in meta-
static RCC [1,7], but the immunotherapeutic approach with
interleukin-2 has achieved preliminary durable partial or
even complete remission of advanced RCC [1]. However,
this requires further evaluation and longer follow-up. Clear-
cell RCC is the most common type, accounting for about
70% of RCC, and most studies have pointed out that there
is a slightly better prognosis with clear-cell RCC than with
granular or mixed RCC. Sarcomatoid RCC has the worst
survival rate [19].
Nevertheless, in moribund patients with multiple
retroperitoneal nodes and duodenal infiltration by multiple
secondaries, curative resection may be impossible and
proximal diversion and palliative surgery, which is not harm-
ful for critically ill patients, could offer the only effective
treatment [7]. On the other hand, metastatic RCC is a hyper-
vascular tumor [4,17]. In patients suffering from massive
and active gastrointestinal bleeding owing to duodenal
metastases from RCC, emergency arteriography and
embolization of the gastroduodenal artery is an alternative
life-saving treatment [17]. Lynch-Nyhan et al reported
successful embolization via the gastroduodenal artery in
two cases of massive gastrointestinal bleeding due to
duodenal metastases of RCC [17].
Endoscopy has long been a standard diagnostic tool for
upper gastrointestinal bleeding. It is also important in eva-
luating metastatic lesions and obtaining biopsies, especially
when radiographic findings in the gastrointestinal tract are
normal [8,20]. However, in hematogenous metastasis to the
gastrointestinal tract, the tumor cells fail to traverse the
capillary network and implant themselves in the submucosa
[8,21]. Owing to the submucosal growth, endoscopic biopsies
are often inadequate [21]. It is also difficult to diagnose
primary or metastatic RCC in small biopsies because of the
Figure 2. (A) Previous nephrectomy specimen, characterized by sheets of clear cells with distinct borders interspersed with numerous thin-walled
blood vessels (hematoxylin & eosin, original magnification, = 400). (B) The duodenum is infiltrated by tumor cells with clear cytoplasm and distinct
cell borders. These tumor cells have the same characteristics as the primary renal cell carcinoma in (A) (hematoxylin & eosin, original magnification,
= 400).
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wide variety of histologic appearances [22], which may
explain why there was no histologic confirmation and
clinical diagnosis until surgical exploration in the present
case. The natural history of duodenal ulcer is to heal, and
there is no association between carcinoma and duodenal
ulcer [23,24]. It is difficult to differentiate malignant and
benign ulcers at initial endoscopy [24]. However, the
possibility of malignancy of the duodenal ulcer should be
considered if the ulcer does not heal after 8 weeks of
medical treatment or if there are polypoid masses or
submucosal tumor masses with elevation and ulceration at
the apex or multiple nodules of varying sizes with tip
ulceration on repeated endoscopic examination [23]. An
immunomarker specific for RCC is not currently available
[22] and there is no universal agreement on the frequency or
type of studies required in the follow-up of patients with
RCC [25].
In summary, life-long follow-up is indicated in patients
with RCC. In nephrectomized patients suffering from
gastrointestinal bleeding, complete endoscopic evaluation
is necessary. Our case emphasizes the necessity of repeat-
ed endoscopic examination and histologic evaluation in
suspected cancer patients. The possibility of upper gas-
trointestinal bleeding due to late recurrence of RCC should
be kept in mind, even though it is rare. If patients are fit for
surgery, there should be no hesitation about performing
surgical exploration and metastatectomy.
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